Korro Bio saw its stock reach all-time lows on disappointing data for its lead pipeline candidate, while Intellia Therapeutics saw analyst downgrades on safety concerns despite releasing positive data ...
Morning Overview on MSN
CRISPR revives ancient gene to block gout and fatty liver
Reviving an ancient human gene that prevents gout and fatty liver disease, scientists at Georgia State University have marked ...
Morning Overview on MSN
Can we clone a dinosaur? Scientists finally answer the Jurassic Park myth
Scientists have recently delivered a definitive verdict on the possibility of cloning dinosaurs, as depicted in the iconic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results